AMPLYX PHARMACEUTICALS INC has a total of 29 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ZAK & LSTROK ADY FARMACEUTYCZN, GLYTHERA LTD and ASTRUM THERAPEUTICS PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 12 | |
#2 | Canada | 4 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Republic of Korea | 2 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | Israel | 1 | |
#9 | Taiwan | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Basic materials chemistry | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Grey Michael | 9 |
#2 | Covel Jonathan A | 9 |
#3 | Mutz Mitchell | 8 |
#4 | Covel Jonathan | 7 |
#5 | Webb Peter | 7 |
#6 | Trzoss Michael | 7 |
#7 | Shaw Karen Joy | 7 |
#8 | Konradi Andrei W | 5 |
#9 | Hodges Michael | 4 |
#10 | Brittain Jason | 4 |
Publication | Filing date | Title |
---|---|---|
WO2020247804A1 | Heterocycle substituted pyridine derivative antifungal agents | |
CA3110860A1 | Compounds and methods for treating fungal infections | |
KR20210023984A | Pyridine derivatives substituted with heterocyclic rings and amino groups | |
KR20200096941A | Heterocycle-substituted pyridine derivatives antifungal agents | |
CA2935801A1 | Antifungal compounds | |
WO2012047762A2 | Antifungal agents | |
WO2011130317A2 | Therapeutic agents having reduced toxicity | |
WO2010132852A2 | Protease inhibitors | |
WO2010077317A2 | Protease inhibitors | |
WO2010065110A2 | Antimicrobials | |
WO2009055042A1 | Enhancing the efficacy of anti-infective therapeutics | |
WO2007053792A2 | Improving the pharmacokinetics of protease inhibitors and other drugs |